Needle Moving Activity Spotted in Teva Pharmaceutical Industries Limited (NYSE:TEVA)

FNY Managed Accounts LLC acquired a new stake in shares of Teva Pharmaceutical Industries Limited in the first quarter valued at approximately $123,000. Credicorp Ltd now has $19.59 billion valuation. It closed at $14.37 lastly. Sharkey Howes & Javer boosted its position in Teva Pharmaceutical Industries Limited by 21.7% in the second quarter. Capital Research Global Investors now owns 76,325,059 shares of the company's stock worth $2,535,518,000 after acquiring an additional 9,260,426 shares in the last quarter. Oppenheimer Holdings, Inc. restated a "buy" rating on shares of Teva Pharmaceutical Industries Limited in a report on Wednesday, May 31st. 11, 2017, but are collecting gains at 0% for the past 12 months.

Stock has got OUTPERFORM rating from 5 analyst (s) whereas last month 5 analyst (s) have given outperform rating.

Following trading activity for Teva Pharmaceutical Industries Limited (NYSE:TEVA), we can see that the stock has moved onto today's list of most actives. The rating was upgraded by Credit Suisse on Monday, October 31 to "Outperform". The company was maintained on Tuesday, July 28 by Argus Research. Finally, Goldman Sachs Group, Inc. The stock of Credicorp Ltd. (USA) (NYSE:BAP) earned "Buy" rating by UBS on Tuesday, August 15. The business had revenue of $5.69 billion during the quarter, compared to analyst estimates of $5.72 billion. Overall, volume was up 1,432.29% over the stocks normal daily volume.

Investors sentiment decreased to 1.02 in 2016 Q4. Its down 0.26, from 1.18 in 2016Q3. 47 funds opened positions while 63 raised stakes. The company have shares float of 912.42 million. Blackrock Institutional Na stated it has 80,267 shares or 0% of all its holdings. Bancorpsouth Inc holds 3,134 shares. (NYSE:MFA). Advisers Lc invested 0% in MFA Financial, Inc. The Delaware-based Blackrock Advsr Limited Com has invested 0% in Ultralife Corp. The dividend payment will be $0.275 per share for the quarter which comes to $1.10 on an annualized basis. Moreover, Thomas J Herzfeld Advisors has 0% invested in Wendys Co (NASDAQ:WEN) for 42 shares. Vanguard Grp holds 327,578 shares or 0% of its portfolio. United Svcs Automobile Association, Texas-based fund reported 17,866 shares. Five research analysts have rated the stock with a sell rating, twenty have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. Therefore 60% are positive. Teva Pharma had 88 analyst reports since July 21, 2015 according to SRatingsIntel.

08/04/2017 - Teva Pharmaceutical Industries Limited had its "hold" rating reiterated by analysts at Jefferies. He brings experience running a global company, has shown an ability to execute against a defined strategy and has a reputation as a straight talker, all of which are keys for Teva. Barclays Capital has "Equal-Weight" rating and $69 target. TEVA's previous stock rating was a Neutral. The rating was maintained by Piper Jaffray with "Hold" on Thursday, August 3.

Teva Pharmaceutical Industries (TEVA) on Monday said Kare Schultz will be its new president and chief executive, ending a search process that began in February. On August 16 the company was downgraded from "Buy" to "Neutral" in a report from Citigroup. The stock has "Overweight" rating by JP Morgan on Thursday, August 11. Leavell Investment Management reported 2,564 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.